These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 17100316)

  • 1. [Process of complexation of prothrombine and fibrin E-fragment].
    Savchuk OM; Krasnobryzha IeM; Horchev VF; Chernyshenko TM; Havryliuk SP; Platonova TM
    Ukr Biokhim Zh (1999); 2006; 78(3):99-105. PubMed ID: 17100316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Fibrin fragment beta 15-118. Inhibitory and complex-forming properties].
    Lugovskoĭ EV; Chudnovets VS; Makogonenko EM; Derzskaia SG; Gogolinskaia GK; Mikhalovskaia LI; Komissarenko SV
    Ukr Biokhim Zh (1978); 1995; 67(4):57-64. PubMed ID: 8553474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-enzymatic activation of prothrombin induced by interaction with fibrin β26-42 region.
    Chernyshenko VO; Chernyshenko TM; Korolova DS; Volynets GP; Kolesnikova IN; Platonova TM; Lugovskoy EV
    Acta Biochim Pol; 2015; 62(3):517-22. PubMed ID: 26317125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The advisability of modifying the current outline of blood coagulation].
    Barkagan ZS; Kuznik BI
    Ter Arkh; 1990; 62(7):81-6. PubMed ID: 2251671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Characteristics of D-domain-containing specific inhibitors of polymerization on the fibrin self-assembly process].
    Platonova TM; Chernyshenko TM; Sokolovs'ka LI
    Ukr Biokhim Zh (1999); 2006; 78(3):124-9. PubMed ID: 17100320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasminogen fragments K 1-3 and K 5 bind to different sites in fibrin fragment DD.
    Grinenko TV; Kapustianenko LG; Yatsenko TA; Yusova OI; Rybachuk VN
    Ukr Biochem J; 2016; 88(3):36-45. PubMed ID: 29235323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Activation of key proenzymes of the blood coagulation system by the fibrin E fragment].
    Platonova TM; Slomins'kyĭ OIu; Chernyshenko TM; Makohonenko IeM
    Ukr Biokhim Zh (1999); 2002; 74(2):25-9. PubMed ID: 12152309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
    Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
    Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orientation of the carboxy-terminal regions of fibrin gamma chain dimers determined from the crosslinked products formed in mixtures of fibrin, fragment D, and factor XIIIa.
    Siebenlist KR; Meh DA; Wall JS; Hainfeld JF; Mosesson MW
    Thromb Haemost; 1995 Oct; 74(4):1113-9. PubMed ID: 8560422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin.
    Spraggon G; Everse SJ; Doolittle RF
    Nature; 1997 Oct; 389(6650):455-62. PubMed ID: 9333233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Degradation of cross-linked fibrin by matrix metalloproteinase 3 (stromelysin 1): hydrolysis of the gamma Gly 404-Ala 405 peptide bond.
    Bini A; Itoh Y; Kudryk BJ; Nagase H
    Biochemistry; 1996 Oct; 35(40):13056-63. PubMed ID: 8855941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prothrombin fragment 1.2 in both treated and untreated hypertensive patients.
    Donders SH; Lustermans FA; van Wersch JW
    Neth J Med; 1993 Oct; 43(3-4):174-8. PubMed ID: 8302396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the coagulation cascade in patients with leptospirosis.
    Chierakul W; Tientadakul P; Suputtamongkol Y; Wuthiekanun V; Phimda K; Limpaiboon R; Opartkiattikul N; White NJ; Peacock SJ; Day NP
    Clin Infect Dis; 2008 Jan; 46(2):254-60. PubMed ID: 18171258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble fibrin degradation products potentiate tissue plasminogen activator-induced fibrinogen proteolysis.
    Weitz JI; Leslie B; Ginsberg J
    J Clin Invest; 1991 Mar; 87(3):1082-90. PubMed ID: 1900308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive exposure of E-neoantigen associated with degradation of crosslinked fibrin by plasmin in vitro.
    Stegnar M; Chen JP
    Thromb Haemost; 1984 Dec; 52(3):315-20. PubMed ID: 6241755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in coagulation and hemodynamics during pregnancy: a prospective longitudinal study of 58 cases.
    Hui C; Lili M; Libin C; Rui Z; Fang G; Ling G; Jianping Z
    Arch Gynecol Obstet; 2012 May; 285(5):1231-6. PubMed ID: 22083312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation markers of coagulation and fibrinolysis in twins: heritability of the prethrombotic state.
    Ariëns RA; de Lange M; Snieder H; Boothby M; Spector TD; Grant PJ
    Lancet; 2002 Feb; 359(9307):667-71. PubMed ID: 11879863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inhibition of the process of Glu-plasminogen activation by tissue activator with fibrin, DDE-complex, and D-dimer using alpha-2-antiplasmin].
    Hrynenko TV; Zadorozhna MB; Platonova TM; Volkov HL
    Ukr Biokhim Zh (1999); 2005; 77(5):45-51. PubMed ID: 16846069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of waist and hip circumference with coagulation and fibrinolysis in postmenopausal women.
    Peverill RE; Teede HJ; Malan E; Kotsopoulos D; Smolich JJ; McGrath BP
    Clin Sci (Lond); 2007 Nov; 113(9):383-91. PubMed ID: 17608627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased activation of blood coagulation in pregnant women with the Factor V Leiden mutation.
    Kjellberg U; van Rooijen M; Bremme K; Hellgren M
    Thromb Res; 2014 Oct; 134(4):837-45. PubMed ID: 25135795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.